Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary study objective is to evaluate the efficacy of Lanreotide Autogel (ATG) 120 mg in combination with Temozolomide in patients with functioning as well as non-functioning, progressive, gastro-entero-pancreatic NET G1 or G2.
Inclusion criteria
- metastatic functioning and non-functioning entero-pancreatic tumours